Yi Hong Liao
Fortuna: 11 M $ al 30/09/2026
Fortuna: 11 M $ al 30/09/2026
Yi Hong Liao is currently a Non-Executive Director at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. since 2025 and a Member of the Supervisory Board at Sichuan Kelun Pharmacy Institute Co., Ltd. since 2020.
Formerly, Ms. Liao worked as an Audit Manager at Kpmg Consulting China Co. Ltd. from 2006 to 2014.
Education includes a graduate degree from Tsinghua University conferred in 2021 and an undergraduate degree from Guangdong University of Foreign Studies conferred in 2020.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 170.000 ( 0,1 % ) | 11 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | 01/06/2025 |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Director/Miembro de la Junta | 05/11/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Kpmg Consulting China Co. Ltd. | Comptroller/Controller/Auditor | 01/11/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong University of Foreign Studies
Guangdong University of Foreign Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kpmg Consulting China Co. Ltd. | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes drugs for treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.